Cognitive Science, EarlyView.
https://ift.tt/2GRmzAf
Αρχειοθήκη ιστολογίου
-
►
2023
(138)
- ► Φεβρουαρίου (74)
- ► Ιανουαρίου (64)
-
►
2022
(849)
- ► Δεκεμβρίου (61)
- ► Σεπτεμβρίου (74)
- ► Φεβρουαρίου (65)
-
►
2021
(2936)
- ► Δεκεμβρίου (59)
- ► Σεπτεμβρίου (180)
- ► Φεβρουαρίου (325)
-
►
2020
(1624)
- ► Δεκεμβρίου (293)
- ► Σεπτεμβρίου (234)
- ► Φεβρουαρίου (28)
-
►
2019
(13362)
- ► Δεκεμβρίου (19)
- ► Σεπτεμβρίου (54)
- ► Φεβρουαρίου (5586)
- ► Ιανουαρίου (5696)
-
▼
2018
(66471)
- ► Δεκεμβρίου (5242)
- ► Σεπτεμβρίου (5478)
-
▼
Μαΐου
(5510)
-
▼
Μαΐ 25
(136)
- Found in Translation: Late Bilinguals Do Automatic...
- Effect of sex on haemocytobiochemical profiling of...
- Antifungal activity of selected natural preservati...
- Antimicrobial activity of fusidic acid in Escheric...
- Cold adaptation and replicable microbial community...
- Maternal depression and cortisol in pregnancy pred...
- Neratinib: Inching up on the cure rate of HER2+ br...
- NRG1 Fusions in KRAS Wild-type Pancreatic Cancer [...
- MLL3 Mutations Disrupt COMPASS Recruitment to Enha...
- Microbial Signals Promote Preleukemic Myeloprolife...
- Endoplasmic Reticulum Stress Drives Latent Pancrea...
- KLHL22 Promotes MTORC1 Activation and Breast Tumor...
- ICU Mortality Similar for Patients With Hematologi...
- American Urological Association, May 18-21
- CDC IDs Outbreak Trends Tied to Treated Recreation...
- FDA Approves Palynziq for Phenylketonuria
- Increase in Tx Candidates With 2017 Hypertension G...
- Giant Colonic Cavernous Hemangioma Causing Hematoc...
- Another new organ! is this a golden age of discove...
- Response to: Gross anatomy examination performance...
- Overview of Systematic Reviews of Advance Care Pla...
- Comparison of EORTC QLQ-C30 and PRO-CTCAETM questi...
- The impact of spasticity on diaphragm contraction:...
- Frequent expression of somatostatin receptor 2a in...
- Immunohistological analysis of the duodenal bulb: ...
- On the performance of parallelisation schemes for ...
- eIF2β, a subunit of translation‐initiation factor ...
- Phospholipase D2 promotes disease progression of r...
- Non-Nutritive Sweeteners Don't Up Blood Glucose Le...
- Mortality Still High After Surgery for Congenital ...
- 60-Day Mortality Not Significantly Lower With ECMO...
- Laws Allowing Service Denial to Sexual Minorities ...
- Antidepressant Prescribing Linked to Lasting Weigh...
- Higher Seafood Intake May Shorten Time to Pregnancy
- CPAP Use May Improve Sexual QOL in Those With Slee...
- Early-Life Weight Associated With Cognitive Factors
- Severe Atopic Eczema Tied to Higher CV Disease Risk
- Certolizumab Looks Promising for Moderate-to-Sever...
- Single Molecule Fluorescence In Situ Hybridization...
- Utilization of Ultrasound Guided Tissue-directed C...
- CARIP-Seq and ChIP-Seq: Methods to Identify Chroma...
- The Determination of Protease Specificity in Mouse...
- Associations between the use of herbal medicines a...
- Varicella zoster virus infections in neurological ...
- Treating schistosomiasis among South African high ...
- Effect of Huaier granule on recurrence after curat...
- Long-term proton pump inhibitor use after Helicoba...
- Prophylactic angiographic embolisation after endos...
- Canalostomy As a Surgical Approach to Local Drug D...
- Enhanced Genome Editing with Cas9 Ribonucleoprotei...
- Dallas paramedics offering free CPR training at ai...
- Payor Logic celebrates hidden superheroes during E...
- The Dantastic Mr. Tox & Howard Episode 12 – Isbist...
- Corrigendum
- Correction to: Ret is essential to mediate GDNF’s ...
- Annexin A5 regulates hepatocarcinoma malignancy vi...
- Neuroglobin mediates neuroprotection of hypoxic po...
- Betulinic acid chemosensitizes breast cancer by tr...
- Dabrafenib–Trametinib Combination Approved for Mel...
- Semaphorin 4D promotes inhibitory synapse formatio...
- Cancers, Vol. 10, Pages 162: p53-Dependent and -In...
- Cancers, Vol. 10, Pages 163: Epstein Barr Virus-As...
- EM Nerd-The Case of the Deceptive Beacon
- Patient-derived multicellular tumor spheroids towa...
- Molecular subtypes in early colorectal cancer asso...
- Acute myeloid leukemia—current data from the 2017 ...
- High expression of forkhead box protein C2 is asso...
- Erlotinib as single agent first line treatment in ...
- A Phase I clinical trial of EUS-guided intratumora...
- IΚΚε cooperates with either MEK or non-canonical N...
- Identification of genes inducing resistance to ion...
- In vivo evaluation of two tissue transglutaminase ...
- Cancers, Vol. 10, Pages 161: KLF10 as a Tumor Supp...
- In vitro-induced erythromycin resistance facilitat...
- Automated Pulmonary Embolism Risk Classification a...
- Slow Infusion of Low‐dose Ketamine Reduces Bothers...
- The Banner of Hope and Solidarity After Mass Murder
- In Reply:
- Accuracy of axial length measurements obtained by ...
- Regulatory NK1.1 − CD4 + NKG2D + subset induced by...
- Maternal nutrient restriction in baboon programs l...
- Regulatory NK1.1 − CD4 + NKG2D + subset induced by...
- Bringing medication prescribing out of the dark: T...
- Reduction of anxiety after treatment with transder...
- Summaries of safety labeling changes approved by F...
- Drug shortages roundtable: Minimizing the impact o...
- Preparation times and costs for various solutions ...
- Tools of the trade: Creativity, innovation, influe...
- Summaries of safety labeling changes approved by F...
- APPOINTMENTS [News]
- Roles of the emergency medicine pharmacist: A syst...
- Proprotein convertase subtilisin/kexin type 9 inhi...
- Pharmacotherapy considerations for long-term manag...
- Catastrophic circulatory collapse after inadverten...
- Incorporating medication indications into the pres...
- News brief [News]
- Educator, editor Harvey A. K. Whitney Jr. dies at ...
- Pharmacists say public awareness could aid 340B pr...
- New drugs and dosage forms [News]
- Illinois hospitals cope with outbreak of bleeding ...
-
▼
Μαΐ 25
(136)
- ► Φεβρουαρίου (4835)
- ► Ιανουαρίου (5592)
-
►
2017
(44259)
- ► Δεκεμβρίου (5110)
- ► Σεπτεμβρίου (5105)
-
►
2016
(7467)
- ► Δεκεμβρίου (514)
- ► Σεπτεμβρίου (1038)
- ► Φεβρουαρίου (793)
Αναζήτηση αυτού του ιστολογίου
Παρασκευή 25 Μαΐου 2018
Found in Translation: Late Bilinguals Do Automatically Activate Their Native Language When They Are Not Using It
Effect of sex on haemocytobiochemical profiling of silver tiger fish ( Datnioides polota Hamilton, 1822)
Abstract
This investigation presents an overview of the effect of sex on haematobiochemical and haemocytomorphometrical aspects of Datnioides polota. For the present study, 15 males and 15 females of Datnioides polota were collected from Balugaon, the central sector of Chilika lagoon of Odisha. Two millilitres of blood samples was collected from each sex through the caudal vein. One millilitre of collected blood was transferred from the syringe into ethylenediaminetetraacetic acid (EDTA) containing vials, for haematological studies and other 1 ml was taken in Eppendorf tube without anticoagulant for analyses of biochemical parameters. Haematological parameters like red blood cell count (RBC), white blood cells count (WBC), haemoglobin, haematocrit, mean cell volume (MCV), mean cell haemoglobin (MCH), mean cell haemoglobin concentration (MCHC), biochemical parameters such as glucose, protein, albumin, globulin, cholesterol, and morphometrical parameters namely length, breadth, area, and N/C ratio of erythrocytes, lymphocytes, monocytes, eosinophils, and neutrophils are analysed in relation to the sex of the fish. Statistical analysis reveals the sex wise significant difference in some haematological parameters like Hb which varies at P < 0.01 level while WBC deviate at P < 0.05 level. All the biochemical parameters show higher value in females in comparison to males except albumin but sex wise significant variation recorded in protein and globulin at P < 0.01 level. In males, the concentration of Hb is positively correlated with RBC and PCV while in females negatively correlated. RBC is positively correlated with PCV in both the sexes at R2 = 0.008 and R2 = 0.9 in male and female, respectively. The morphometry of blood cells such as monocytes and lymphocytes shows significant sexual dimorphism. The cellular length and area of monocytes deviate at the level of P < 0.01 and breadth at P < 0.05 level. The cellular and nuclear breadth of lymphocyte vary significantly at the level of P < 0.05 and P < 0.001, respectively. The results of this study may serve as a reference value for haemocytological and biochemical parameters of this species which in turn helps in diagnosing diseases and increasing fish production.
https://ift.tt/2kribzp
Antifungal activity of selected natural preservatives against the foodborne molds Penicillium verrucosum and Aspergillus westerdijkiae
https://ift.tt/2J9o4z9
Antimicrobial activity of fusidic acid in Escherichia coli is dependent on the relative levels of ribosome recycling factor (RRF) and elongation factor G (EFG)
https://ift.tt/2KRoFTh
Cold adaptation and replicable microbial community development during long-term low temperature anaerobic digestion treatment of synthetic sewage
https://ift.tt/2JbDnHL
Maternal depression and cortisol in pregnancy predict offspring emotional reactivity in the preschool period
Developmental Psychobiology, EarlyView.
https://ift.tt/2LxfwAs
Neratinib: Inching up on the cure rate of HER2+ breast cancer?
Neratinib was recently approved by FDA for extended adjuvant treatment of HER-2 positive breast cancer. ExteNET trial showed improvement in invasive disease-free survival (iDFS) in the neratinib arm compared to placebo. The benefit was more pronounced in patients with ER+/HER2+ tumors, suggesting bidirectional crosstalk between the two pathways.
https://ift.tt/2INwxss
NRG1 Fusions in KRAS Wild-type Pancreatic Cancer [Research Briefs]
We used whole-genome and transcriptome sequencing to identify clinically actionable genomic alterations in young adults with pancreatic ductal adenocarcinoma (PDAC). Molecular characterization of 17 PDAC patients enrolled in a precision oncology program revealed gene fusions amenable to pharmacologic inhibition by small-molecule tyrosine kinase inhibitors in all patients with KRAS wild-type (KRASwt) tumors (4 of 17). These alterations included recurrent NRG1 rearrangements predicted to drive PDAC development through aberrant ERBB receptor-mediated signaling, and pharmacologic ERBB inhibition resulted in clinical improvement and remission of liver metastases in two patients with NRG1-rearranged tumors that had proved resistant to standard treatment. Our findings demonstrate that systematic screening of KRASwt tumors for oncogenic fusion genes will substantially improve the therapeutic prospects for a sizeable fraction of PDAC patients.
https://ift.tt/2GRG4sC
MLL3 Mutations Disrupt COMPASS Recruitment to Enhancer Chromatin [Research Watch]
Mutations in the MLL3 PHD domain promote oncogenesis by disrupting its interaction with BAP1.
https://ift.tt/2kqpdnP
Microbial Signals Promote Preleukemic Myeloproliferation in Tet2-/- Mice [Research Watch]
TET2 deficiency increases systemic bacterial dissemination to promote preleukemic myeloproliferation (PMP).
https://ift.tt/2sc8NDb
Endoplasmic Reticulum Stress Drives Latent Pancreatic Tumor Metastases [Research Watch]
Unresolved ER stress promotes quiescence and immune escape of latent disseminated PDAC.
https://ift.tt/2ILo20P
KLHL22 Promotes MTORC1 Activation and Breast Tumorigenesis [Research Watch]
Amino acids promote CUL3-KLHL22–mediated DEPDC5 degradation to relieve mTORC1 inhibition.
https://ift.tt/2sc8NmF
ICU Mortality Similar for Patients With Hematologic CA ± Chemo
FRIDAY, May 25, 2018 -- Short-term mortality is similar among patients with hematologic cancer who receive chemotherapy while in the intensive care unit (ICU) versus those who do not, according to a study published online May 4 in Cancer. Stephen M....
https://ift.tt/2ktsItQ
American Urological Association, May 18-21
The American Urological Association's 2018 Annual Meeting The annual meeting of the American Urological Association was held from May 18 to 21 in San Francisco and attracted more than 12,000 participants from around the world, including clinicians,...
https://ift.tt/2sehmgL
CDC IDs Outbreak Trends Tied to Treated Recreational Water
FRIDAY, May 25, 2018 -- Outbreaks associated with treated recreational water with confirmed infectious etiology are usually caused by Cryptosporidium, Legionella, or Pseudomonas, according to research published in the May 18 issue of the U.S....
https://ift.tt/2ktsHGi
FDA Approves Palynziq for Phenylketonuria
FRIDAY, May 25, 2018 -- Palynziq (pegvaliase-pqpz) has been approved by the U.S. Food and Drug Administration to treat phenylketonuria, or PKU. Palynziq is a novel enzyme therapy for adult patients with PKU with uncontrolled blood phenylalanine...
https://ift.tt/2GSforB
Increase in Tx Candidates With 2017 Hypertension Guidelines
FRIDAY, May 25, 2018 -- The 2017 American College of Cardiology/American Heart Association hypertension guideline is associated with an increase in the proportion of adults recommended for antihypertensive treatment compared with the 2014 guideline,...
https://ift.tt/2ILLCL1
Giant Colonic Cavernous Hemangioma Causing Hematochezia in a 14-Year-Old Boy
A 14-year-old boy presented with intermittent hematochezia for 2 weeks. He reported a similar episode of hematochezia 1 year ago that was regarded as colitis. His medical history was unremarkable. Physical examination showed a nontender, soft, palpable mass at the upper right quadrant of the abdomen. His hemoglobin level was 7.3 g/dL (normal range, 13.0–16.0 g/dL). A computed tomography scan of his abdomen showed asymmetric segmental wall thickening with scattered punctuate calcification (Figure A, white arrow) and heterogeneous enhancement from the midtransverse colon to the hepatic flexure (Figure A, black arrow).
https://ift.tt/2IN2u3U
Another new organ! is this a golden age of discovery in anatomy?
Clinical Anatomy, EarlyView.
https://ift.tt/2J8s4zG
Response to: Gross anatomy examination performances in relation to medical students' knowledge of classical Latin and Greek
Clinical Anatomy, EarlyView.
https://ift.tt/2KU4K63
Overview of Systematic Reviews of Advance Care Planning: Summary of Evidence and Global Lessons
Advance care planning (ACP) involves important decision-making about future medical needs. The high volume and disparate nature of ACP research make it difficult to grasp the evidence and derive clear policy lessons for policymakers and clinicians.
https://ift.tt/2kuNBEN
Comparison of EORTC QLQ-C30 and PRO-CTCAETM questionnaires on six symptom items
Clinical studies have over the past decade paid increasing attention to health-related quality of life(HRQOL) data. Multiple questionnaires are often administered resulting in overlapping questions increasing patient burden.
https://ift.tt/2GNGC2J
The impact of spasticity on diaphragm contraction: electrophysiological assessment
Amyotrophic Lateral Sclerosis (ALS) is a rapidly progressive neurodegenerative disease in which ventilatory insufficiency and other respiratory complications account for the majority of deaths. Respiratory failure is a presenting feature in about 3-5% of the patients (de Carvalho et al., 1996).
https://ift.tt/2GSyEoS
Frequent expression of somatostatin receptor 2a in olfactory neuroblastomas: a new and distinctive feature
Olfactory neuroblastoma (ONB) is a malignant neuroendocrine neoplasm with a usually slow course, but with considerable recurrence rate. Many neuroendocrine tumors have shown good response to the treatment with somatostatin analogues and somatostatin radioreceptor therapy. In ONBs, there are scarce data on somatostatin-based treatment and the cellular expression of somatostatin receptors (SSTR), the prerequisite for binding and effect of somatostatin on normal and tumor cells. The aim of our study was to investigate the immunohistochemical expression of somatostatin receptor (SSTR) 2A and 5 in a cohort of 40 ONBs.
https://ift.tt/2s8AtJL
Immunohistological analysis of the duodenal bulb: a new method for celiac disease diagnosis in children
Anti-tissue transglutaminase antibodies (anti-tTG) have simplified celiac disease (CD) diagnosis. However, in atypical forms of CD, intestinal biopsy is still required. This prospective study investigates whether histological analysis of the duodenal bulb combined with intestinal IgA anti-tTG deposit immunoassay makes CD diagnosis possible in at-risk children with low concentrations of serum anti-tTG.
https://ift.tt/2IOCKnR
On the performance of parallelisation schemes for particle filtering
Considerable effort has been recently devoted to the design of schemes for the parallel implementation of sequential Monte Carlo (SMC) methods for dynamical systems, also widely known as particle filters (PFs)...
https://ift.tt/2Lw4WtB
eIF2β, a subunit of translation‐initiation factor EIF2, is a potential therapeutic target for non‐small cell lung cancer
Cancer Science, EarlyView.
https://ift.tt/2KVGr7U
Phospholipase D2 promotes disease progression of renal cell carcinoma through the induction of angiogenin
Cancer Science, EarlyView.
https://ift.tt/2LsJzt0
Non-Nutritive Sweeteners Don't Up Blood Glucose Levels
FRIDAY, May 25, 2018 -- Consumption of non-nutritive sweeteners (NNSs) does not increase blood glucose levels, according to a review published online May 15 in the European Journal of Clinical Nutrition. Alexander D. Nichol, from the University of...
https://ift.tt/2s6AduK
Mortality Still High After Surgery for Congenital Heart Defects
FRIDAY, May 25, 2018 -- Long-term mortality after congenital heart surgery is higher than that of the general population for all forms of congenital heart defects (CHDs), according to a study published in the May 29 issue of the Journal of the...
https://ift.tt/2IRomHl
60-Day Mortality Not Significantly Lower With ECMO in ARDS
FRIDAY, May 25, 2018 -- For patients with very severe acute respiratory distress syndrome (ARDS), 60-day mortality is not significantly lower with venovenous extracorporeal membrane oxygenation (ECMO) than with continued conventional treatment,...
https://ift.tt/2s6AbTE
Laws Allowing Service Denial to Sexual Minorities Tied to Distress
FRIDAY, May 25, 2018 -- Laws permitting denial of services to same-sex couples are associated with an increase in sexual minority adults experiencing mental distress, according to a study published online May 23 in JAMA Psychiatry. Julia Raifman,...
https://ift.tt/2KTZWh2
Antidepressant Prescribing Linked to Lasting Weight Gain
FRIDAY, May 25, 2018 -- Antidepressant prescribing is associated with long-term increased risk of weight gain, according to a study published online May 23 in The BMJ. Rafael Gafoor, Ph.D., from King's College London, and colleagues examined the...
https://ift.tt/2s6Aa22
Higher Seafood Intake May Shorten Time to Pregnancy
FRIDAY, May 25, 2018 -- Higher seafood intake is tied to a shorter time to pregnancy (TTP), according to a study published online May 23 in the Journal of Clinical Endocrinology & Metabolism. Audrey J. Gaskins, Sc.D., from Harvard University in...
https://ift.tt/2KTZTBS
CPAP Use May Improve Sexual QOL in Those With Sleep Apnea
FRIDAY, May 25, 2018 -- Successful continuous positive airway pressure (CPAP) use for obstructive sleep apnea may be associated with improved sexual quality of life (QOL), according to a study published online May 24 in JAMA Otolaryngology-Head...
https://ift.tt/2s6A76m
Early-Life Weight Associated With Cognitive Factors
FRIDAY, May 25, 2018 -- Early-life weight status has an inverse association with some cognitive abilities in children, according to a study published online May 23 in Obesity. Nan Li, Ph.D., from Brown University in Providence, R.I., and colleagues...
https://ift.tt/2KWh9GR
Severe Atopic Eczema Tied to Higher CV Disease Risk
FRIDAY, May 25, 2018 -- Adults with severe atopic eczema are at increased risk of cardiovascular disease, according to a study published online May 23 in The BMJ. Richard J. Silverwood, Ph.D., from the London School of Hygiene and Tropical Medicine,...
https://ift.tt/2s6A2Q6
Certolizumab Looks Promising for Moderate-to-Severe Psoriasis
FRIDAY, May 25, 2018 -- Twice-weekly certolizumab biologic appears to be both safe and effective for the treatment of moderate-to-severe chronic plaque psoriasis, according to a study published online April 13 in the Journal of the American Academy...
https://ift.tt/2ILPG9T
Single Molecule Fluorescence In Situ Hybridization (smFISH) Analysis in Budding Yeast Vegetative Growth and Meiosis
https://ift.tt/2LvMIrT
Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts
https://ift.tt/2IQCP6B
CARIP-Seq and ChIP-Seq: Methods to Identify Chromatin-Associated RNAs and Protein-DNA Interactions in Embryonic Stem Cells
Here, we describe methods to perform ChIP-Seq and CARIP-Seq, including library preparation for next-generation sequencing, to generate global epigenomic and chromatin-associated RNA maps in ES cells.
https://ift.tt/2IRkiXB
The Determination of Protease Specificity in Mouse Tissue Extracts by MALDI-TOF Mass Spectrometry: Manipulating PH to Cause Specificity Changes
https://ift.tt/2IPk2g8
Associations between the use of herbal medicines and adverse pregnancy outcomes in rural Malawi: a secondary analysis of randomised controlled trial data
The use of herbal medicines during pregnancy is very high globally and previous studies have pointed out possible associations with adverse pregnancy outcomes. Nevertheless, the safety of herbal medicines in p...
https://ift.tt/2xaQ804
Varicella zoster virus infections in neurological patients: a clinical study
Varicella zoster virus (VZV) reactivation is a common infectious disease in neurology and VZV the second most frequent virus detected in encephalitis. This study investigated characteristics of clinical and la...
https://ift.tt/2s8Dqdw
Treating schistosomiasis among South African high school pupils in an endemic area, a qualitative study
Schistosomiasis, a neglected tropical disease caused by parasites that infest open water sources such as rivers and dams may increase susceptibility to HIV. Mass-treatment with praziquantel tablets, recommende...
https://ift.tt/2xaGqLa
Effect of Huaier granule on recurrence after curative resection of HCC: a multicentre, randomised clinical trial
Objective
There is little evidence that adjuvant therapy after radical surgical resection of hepatocellular carcinoma (HCC) improves recurrence-free survival (RFS) or overall survival (OS). We conducted a multicentre, randomised, controlled, phase IV trial evaluating the benefit of an aqueous extract of Trametes robinophila Murr (Huaier granule) to address this unmet need.
Design and resultsA total of 1044 patients were randomised in 2:1 ratio to receive either Huaier or no further treatment (controls) for a maximum of 96 weeks. The primary endpoint was RFS. Secondary endpoints included OS and tumour extrahepatic recurrence rate (ERR). The Huaier (n=686) and control groups (n=316) had a mean RFS of 75.5 weeks and 68.5 weeks, respectively (HR 0.67; 95% CI 0.55 to 0.81). The difference in the RFS rate between Huaier and control groups was 62.39% and 49.05% (95% CI 6.74 to 19.94; p=0.0001); this led to an OS in the Huaier and control groups of 95.19% and 91.46%, respectively (95% CI 0.26 to 7.21; p=0.0207). The tumour ERR between Huaier and control groups was 8.60% and 13.61% (95% CI –12.59 to –2.50; p=0.0018), respectively.
ConclusionsThis is the first nationwide multicentre study, involving 39 centres and 1044 patients, to prove the effectiveness of Huaier granule as adjuvant therapy for HCC after curative liver resection. It demonstrated a significant prolongation of RFS and reduced extrahepatic recurrence in Huaier group.
Trial registrationNCT01770431; Post-results.
https://ift.tt/2IRhbPm
Long-term proton pump inhibitor use after Helicobacter pylori eradication may create a gastric environment for N-nitrosamine formation and gastric cancer development
I read with great interest the recent article by Cheung et al reporting a duration-dependent association between the long-term use proton pump inhibitors (PPI) and an increased risk of gastric cancer in patients, even after Helicobacter pylori (HP) eradication therapy.1 Chronic gastritis due to HP infection induces mutagenesis through deamination and nitration of DNA, via a reaction with inducible nitric oxide synthase (iNOS)-derived NO and superoxide from inflammatory cells.2 However, Cheung et al further demonstrated that continued PPI treatment, even after HP eradication, could also increase the risk for gastric cancer. I support the findings of this paper from the perspective of the importance of physiological acidity in the formation of carcinogenic N-nitroso compounds (NOC) in the stomach.
Gastric acidity does not solely contribute to the digestion of food and as a first-line host defence against swallowed pathogens but also suppresses NOC formation in the stomach.
https://ift.tt/2IMOSWA
Prophylactic angiographic embolisation after endoscopic control of bleeding to high-risk peptic ulcers: a randomised controlled trial
Objectives
In the management of patients with bleeding peptic ulcers, recurrent bleeding is associated with high mortality. We investigated if added angiographic embolisation after endoscopic haemostasis to high-risk ulcers could reduce recurrent bleeding.
DesignAfter endoscopic haemostasis to their bleeding gastroduodenal ulcers, we randomised patients with at least one of these criteria (ulcers≥20 mm in size, spurting bleeding, hypotensive shock or haemoglobin<9 g/dL) to receive added angiographic embolisation or standard treatment. Our primary endpoint was recurrent bleeding within 30 days.
ResultsBetween January 2010 and July 2014, 241 patients were randomised (added angiographic embolisation n=118, standard treatment n=123); 22 of 118 patients (18.6%) randomised to angiography did not receive embolisation. In an intention-to-treat analysis, 12 (10.2%) in the embolisation and 14 (11.4%) in the standard treatment group reached the primary endpoint (HR 1.14, 95% CI 0.53 to 2.46; p=0.745). The rate of reinterventions (13 vs 17; p=0.510) and deaths (3 vs 5, p=0.519) were similar. In a per-protocol analysis, 6 of 96 (6.2%) rebled after embolisation compared with 14 of 123 (11.4%) in the standard treatment group (HR 1.89, 95% CI 0.73 to 4.92; p=0.192). None of 96 patients died after embolisation compared with 5 (4.1%) deaths in the standard treatment group (p=0.108). In a posthoc analysis, embolisation reduced recurrent bleeding only in patients with ulcers≥15 mm in size (2 (4.5%) vs 12 (23.1%); p=0.027).
ConclusionsAfter endoscopic haemostasis, added embolisation does not reduce recurrent bleeding.
Trial registration numberhttps://ift.tt/2IQiQVD
Canalostomy As a Surgical Approach to Local Drug Delivery into the Inner Ears of Adult and Neonatal Mice
Here we describe canalostomy procedure which allows local drug delivery into the inner ears of adult and neonatal mice through the semicircular canal with minimum damage to hearing and vestibular function. This method can be used to inoculate viral vectors, pharmaceuticals, and small molecules into the mouse inner ear.
https://ift.tt/2KQxahp
Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
Utilizing a preassembled Cas9 ribonucleoprotein complex (RNP) is a powerful method for precise, efficient genome editing. Here, we highlight its utility across a broad range of cells and organisms, including primary human cells and both classic and emerging model organisms.
https://ift.tt/2Lsmab8
Dallas paramedics offering free CPR training at airport
Paramedics from several EMS agencies teaching hands-only CPR to passengers at the Dallas/Fort Worth International Airport
https://ift.tt/2IOTETC
Payor Logic celebrates hidden superheroes during EMS Week 2018
EMS practitioners and billing administrators acknowledged for industry impact
https://ift.tt/2xbNOpH
The Dantastic Mr. Tox & Howard Episode 12 – Isbister Bitsy Spider
https://ift.tt/2KRMfzc Join Dan (@drusyniak) &howard (@heshiegreshie) as they palaver with Dr. Geoff Isbister (@geoff_isbister) about the poison playground that is Australia. Snakes, spiders and quetiapine, oh my! Learn what color of snake to look out for (hint: all of them), learn how Australians do research (on themselves), and why generally leaving your house down under […]
EMCrit Project by Tox & Hound.
https://ift.tt/2sbr17S
Corrigendum
https://ift.tt/2GPZmOR
Correction to: Ret is essential to mediate GDNF’s neuroprotective and neuroregenerative effect in a Parkinson disease mouse model
Correction to: Ret is essential to mediate GDNF's neuroprotective and neuroregenerative effect in a Parkinson disease mouse model
Correction to: Ret is essential to mediate GDNF's neuroprotective and neuroregenerative effect in a Parkinson disease mouse model, Published online: 25 May 2018; doi:10.1038/s41419-018-0636-4
Correction to: Ret is essential to mediate GDNF's neuroprotective and neuroregenerative effect in a Parkinson disease mouse modelhttps://ift.tt/2xf3Vmo
Annexin A5 regulates hepatocarcinoma malignancy via CRKI/II-DOCK180-RAC1 integrin and MEK-ERK pathways
Annexin A5 regulates hepatocarcinoma malignancy via CRKI/II-DOCK180-RAC1 integrin and MEK-ERK pathways
Annexin A5 regulates hepatocarcinoma malignancy via CRKI/II-DOCK180-RAC1 integrin and MEK-ERK pathways, Published online: 25 May 2018; doi:10.1038/s41419-018-0685-8
Annexin A5 regulates hepatocarcinoma malignancy via CRKI/II-DOCK180-RAC1 integrin and MEK-ERK pathwayshttps://ift.tt/2s813mi
Neuroglobin mediates neuroprotection of hypoxic postconditioning against transient global cerebral ischemia in rats through preserving the activity of Na+/K+ ATPases
Neuroglobin mediates neuroprotection of hypoxic postconditioning against transient global cerebral ischemia in rats through preserving the activity of Na+/K+ ATPases
Neuroglobin mediates neuroprotection of hypoxic postconditioning against transient global cerebral ischemia in rats through preserving the activity of Na<sup>+</sup>/K<sup>+</sup> ATPases, Published online: 25 May 2018; doi:10.1038/s41419-018-0656-0
Neuroglobin mediates neuroprotection of hypoxic postconditioning against transient global cerebral ischemia in rats through preserving the activity of Na+/K+ ATPaseshttps://ift.tt/2IQWTpd
Betulinic acid chemosensitizes breast cancer by triggering ER stress-mediated apoptosis by directly targeting GRP78
Betulinic acid chemosensitizes breast cancer by triggering ER stress-mediated apoptosis by directly targeting GRP78
Betulinic acid chemosensitizes breast cancer by triggering ER stress-mediated apoptosis by directly targeting GRP78, Published online: 25 May 2018; doi:10.1038/s41419-018-0669-8
Betulinic acid chemosensitizes breast cancer by triggering ER stress-mediated apoptosis by directly targeting GRP78https://ift.tt/2s8jUxO
Dabrafenib–Trametinib Combination Approved for Melanoma, Anaplastic Thyroid Cancer
FDA recently approved the targeted-drug combination to treat patients with advanced melanoma and a subset of patients with a rare and aggressive form of thyroid cancer whose tumors have a specific mutation in the BRAF gene.
https://ift.tt/2INfrXx
Cancers, Vol. 10, Pages 162: p53-Dependent and -Independent Epithelial Integrity: Beyond miRNAs and Metabolic Fluctuations
Cancers, Vol. 10, Pages 162: p53-Dependent and -Independent Epithelial Integrity: Beyond miRNAs and Metabolic Fluctuations
Cancers doi: 10.3390/cancers10060162
Authors: Tsukasa Oikawa Yutaro Otsuka Hisataka Sabe
In addition to its classical roles as a tumor suppressor, p53 has also been shown to act as a guardian of epithelial integrity by inducing the microRNAs that target transcriptional factors driving epithelial–mesenchymal transition. On the other hand, the ENCODE project demonstrated an enrichment of putative motifs for the binding of p53 in epithelial-specific enhancers, such as CDH1 (encoding E-cadherin) enhancers although its biological significance remained unknown. Recently, we identified two novel modes of epithelial integrity (i.e., maintenance of CDH1 expression): one involves the binding of p53 to a CDH1 enhancer region and the other does not. In the former, the binding of p53 is necessary to maintain permissive histone modifications around the CDH1 transcription start site, whereas in the latter, p53 does not bind to this region nor affect histone modifications. Furthermore, these mechanisms likely coexisted within the same tissue. Thus, the mechanisms involved in epithelial integrity appear to be much more complex than previously thought. In this review, we describe our findings, which may instigate further experimental scrutiny towards understanding the whole picture of epithelial integrity as well as the related complex asymmetrical functions of p53. Such understanding will be important not only for cancer biology but also for the safety of regenerative medicine.
https://ift.tt/2xcxSUb
Cancers, Vol. 10, Pages 163: Epstein Barr Virus-Associated Hodgkin Lymphoma
Cancers, Vol. 10, Pages 163: Epstein Barr Virus-Associated Hodgkin Lymphoma
Cancers doi: 10.3390/cancers10060163
Authors: Antonino Carbone Annunziata Gloghini
Abstract: Classical Hodgkin lymphoma (cHL) is a distinct clinical and pathological entity with heterogeneous genetic and virological features, with regards to Epstein–Barr virus (EBV) infection. The variable association of cHL with EBV infection is probably related to the different levels of patient immunosuppression, both locally in the tumour tissue and at the systemic level. This review paper focuses on EBV-related cHL highlighting pathogenetic and pathological features that may impact pathobiology-driven treatment for the affected patients.
https://ift.tt/2LsU0Ni
EM Nerd-The Case of the Deceptive Beacon
Let's face it, we have an unhealthy relationship with antibiotics. We are all aware that we are currently in an antibiotic resistance crisis that is driven by overuse. And despite our enlightenment we cannot seem to stop prescribing antibiotics for complaints that have been clearly shown not to require antibiotics. And so, given our appalling […]
EMCrit Project by Rory Spiegel.
https://ift.tt/2J67aBq
Patient-derived multicellular tumor spheroids towards optimized treatment for patients with hepatocellular carcinoma
Abstract
Background
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide and has poor prognosis. Specially, patients with HCC usually have poor tolerance of systemic chemotherapy, because HCCs develop from chronically damaged tissue that contains considerable inflammation, fibrosis, and cirrhosis. Since HCC exhibits highly heterogeneous molecular characteristics, a proper in vitro system is required for the study of HCC pathogenesis. To this end, we have established two new hepatitis B virus (HBV) DNA-secreting HCC cell lines from infected patients.
Methods
Based on these two new HCC cell lines, we have developed chemosensitivity assays for patient-derived multicellular tumor spheroids (MCTSs) in order to select optimized anti-cancer drugs to provide more informative data for clinical drug application. To monitor the effect of the interaction of cancer cells and stromal cells in MCTS, we used a 3D co-culture model with patient-derived HCC cells and stromal cells from human hepatic stellate cells, human fibroblasts, and human umbilical vein endothelial cells to facilitate screening for optimized cancer therapy.
Results
To validate our system, we performed a comparison of chemosensitivity of the three culture systems, which are monolayer culture system, tumor spheroids, and MCTSs of patient-derived cells, to sorafenib, 5-fluorouracil, and cisplatin, as these compounds are typically standard therapy for advanced HCC in South Korea.
Conclusion
In summary, these findings suggest that the MCTS culture system is the best methodology for screening for optimized treatment for each patients with HCC, because tumor spheroids not only mirror the 3D cellular context of the tumors but also exhibit therapeutically relevant pathophysiological gradients and heterogeneity of in vivo tumors.
https://ift.tt/2LtFHIf
Molecular subtypes in early colorectal cancer associated with clinical features and patient prognosis
Abstract
Purpose
After surgical resection, an ample prognosis variability among stages is observed. Multiple prognostic factors are individually studied and some CRC classifiers have been proposed. Not one have been implemented into clinical practice.
Methods/patients
We classified 105 patients with resected CRC (stage I–III) into five molecular subtypes using BRAFV600E and RAS (KRAS; NRAS) status, and the expression of DNA mismatch repair (MMR) proteins (MLH1 and MSH2). Clinicopathological features and DFS) of distincts groups were evaluated.
Results and conclusions
RAS and BRAFV600E mutations were detected in 43.8 and 11.4% of patients, respectively. 19% of tumours had lack of expression of any MMR proteins reflecting a system deficiency (dMMR). Patients with any RAS mutation had lower DFS that patients with RAS wild type (wt) (40.23 vs 45.26 months; p value = 0.035). Of a total of five molecular subtypes, three were MMR proficient (pMMR): RAS mutated (39%), BRAFV600E mutated (6.7%) and RAS/BRAFV600E wt (35.2%); and two were dMMR: BRAFV600E mutated (4.8%) and BRAFV600E wt (14.3%). Left side tumours were more frequently observed in pMMR/RAS and BRAFV600E wt subtype, and right side tumours in dMMR subtypes. Among the three pMMR subtypes, a benefit survival was observed for patients without any mutation in BRAFv600E or RAS oncogenes (median of DFS = 45.5 vs 40.98 months in RAS mutated group; p = 0.084 and vs 34.13 in BRAFv600E mutated group; p = 0.031). Molecular classification using these biomarkers can be useful to identify groups with differences in prognosis.
https://ift.tt/2IIEOxC
Acute myeloid leukemia—current data from the 2017 American Society of Hematology meeting
Summary
Purpose
To review data on acute myeloid leukemia (AML) presented at the 2017 meeting of the American Society of Hematology (ASH) and to discuss these data within the framework of future developments for the disease.
Results and conclusion
Data generated by next generation sequencing (NGS) may be used for primary diagnosis, therapy selection and monitoring as well as characterization of persons at risk for AML development. After validation, this method will need to be implemented in general practice in the future. For treatment more targeted therapies—single agent or in combination with standard chemotherapy or low-dose treatment approaches—will become available and complement our armamentarium against AML. Among others interesting targets discussed are FLT-3, IDH1 and 2, BCL-2, MEK, E‑selectin, MDM2 and JAK1. Furthermore, maintenance after induction chemotherapy is again being considered for the management of AML.
https://ift.tt/2GMCxfa
High expression of forkhead box protein C2 is associated with aggressive phenotypes and poor prognosis in clinical hepatocellular carcinoma
Abstract
Background
Hepatocellular carcinoma (HCC) is one of the major causes of tumor death; thus, the identification of markers related to its diagnosis and prognosis is critical. Previous studies have revealed that epithelial-to-mesenchymal transition (EMT) is involved in tumor invasion and metastasis, and the forkhead box protein C2 (FOXC2) has been shown to promote tumor cell proliferation, invasion, and EMT. In the present study, we examined the clinicopathological significance of FOXC2 and EMT-related markers in clinical HCC specimens and identified factors related to the diagnosis and prognosis of HCC.
Methods
The expression of FOXC2 and EMT-related markers was evaluated by immunohistochemistry in 84 cases of hepatocellular carcinoma.
Results
A high expression of FOXC2 was observed in 26 of 84 cases, and expression was significantly correlated with background liver cirrhosis, poor tumor differentiation, high serum AFP, and elevated cell proliferation markers. In addition, this high expression was related to the induction of the Cadherin switch and vimentin expression and was an independent predictor for poor prognosis.
Conclusion
The high expression of FOXC2 in HCC is correlated with tumor malignancy and poor prognosis, suggesting that FOXC2 may be an important prognostic factor for HCC.
https://ift.tt/2IPAcSx
Erlotinib as single agent first line treatment in locally advanced or metastatic activating EGFR mutation-positive lung adenocarcinoma (CEETAC): an open-label, non-randomized, multicenter, phase IV clinical trial
Abstract
Background
Erlotinib is approved for the first line treatment of epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer. Since the number of prospective studies in Caucasian patients treated in routine clinical setting is limited we conducted a multicenter, phase IV clinical trial to determine the efficacy and safety of erlotinib and to demonstrate the feasibility of the validated standardized companion diagnostic method of EGFR mutation detection.
Methods
651 chemonaive, cytologically or histologically verified advanced stage lung adenocarcinoma patients from Hungary, Turkey and Latvia were screened for exon19 microdeletions and exon21 L858R EGFR mutations using the companion diagnostic EGFR test. EGFR mutation-positive, locally advanced or metastatic lung adenocarcinoma patients received as first line treatment erlotinib at 150 mg/day. The primary endpoint was progression-free survival (PFS).
Results
62 EGFR mutation-positive patients (9.5% of screened) were included in the safety/intent-to-treat cohort. Median PFS was 12.8 months (95%CI, 9.9–15.8), objective response rate and one-year survival was 66.1% and 82.5%, respectively. Most frequent treatment related adverse events were diarrhoea and rash. Eastern Oncology Cooperative Group Performance Status (ECOG PS), smoking status and M1a/M1b disease stage were significant prognosticators of PFS (p = 0.017, p = 0.045 and p = 0.002, respectively). There was no significant difference in PFS between the subgroups stratified by gender, age or exon19 vs exon21 mutation.
Conclusions
Our study confirmed the efficacy and safety of first line erlotinib monotherapy in Caucasian patients with locally advanced or metastatic lung adenocarcinoma carrying activating EGFR mutations based on the screening with the approved companion diagnostic procedure.
Trial registration
ClinicalTrials.gov Identifier: NCT01609543.
https://ift.tt/2s6iILe
A Phase I clinical trial of EUS-guided intratumoral injection of the oncolytic virus, HF10 for unresectable locally advanced pancreatic cancer
Abstract
Background
Prognosis of pancreatic cancer is poor with a 5-year survival rate of only 7%. Although several new chemotherapy treatments have shown promising results, all patients will eventually progress, and we need to develop newer chemotherapy treatments to improve response rates and overall survival (OS). HF10 is a spontaneously mutated oncolytic virus derived from a herpes simplex virus-1, and it has potential to show strong antitumor effect against malignancies without damaging normal tissue. We aimed to evaluate the safety and anti-tumor effectiveness in phase I dose-escalation trial of direct injection of HF10 into unresectable locally advanced pancreatic cancer under endoscopic ultrasound (EUS)-guidance in combination with erlotinib and gemcitabine administration. The mid-term results have been previously reported and here we report the final results of our study.
Methods
This was a single arm, open-label Phase I trial. HF10 was injected once every 2 weeks and continued up to four times in total unless dose-limiting toxicity (DLT) appears. A total of nine subjects in three Cohorts with dose-escalation were planned to be enrolled in this trial. The primary endpoint was the safety assessment and the secondary endpoint was the efficacy assessment.
Results
Twelve patients enrolled in this clinical trial, and ten subjects received this therapy. Five patients showed Grade III myelosuppression and two patients developed serious adverse events (AEs) (perforation of duodenum, hepatic dysfunction). However, all of these events were judged as AEs unrelated to HF10. Tumor responses were three partial responses (PR), four stable diseases (SD), and two progressive diseases (PD) out of nine subjects who completed the treatment. Target lesion responses were three PRs and six SDs. The median progression free survival (PFS) was 6.3 months, whereas the median OS was 15.5 months. Two subjects from Cohort 1 and 2 showed downstaging and finally achieved surgical complete response (CR).
Conclusions
HF10 direct injection under EUS-guidance in combination with erlotinib and gemcitabine was a safe treatment for locally advanced pancreatic cancer. Combination therapy of HF10 and chemotherapy should be explored further in large prospective studies. Trial registration: This study was prospectively registered in UMIN-CTR (UMIN000010150) on March 4th, 2013.
https://ift.tt/2IJMGuY
IΚΚε cooperates with either MEK or non-canonical NF-kB driving growth of triple-negative breast cancer cells in different contexts
Abstract
Background
Metastatic breast cancer carries a poor prognosis despite the success of newly targeted therapies. Treatment options remain especially limited for the subtype of triple negative breast cancer (TNBC). Several signaling pathways, including NF-κB, are altered in TNBC, and the complexity of this disease implies multi-faceted pathway interactions. Given that IKKε behaves as an oncogene in breast cancer, we hypothesized that IKKε regulates NF-κB signaling to control diverse oncogenic functions in TNBC.
Methods
Vector expression and RNA interference were used to investigate the functional role of IKKε in triple-negative breast cancer cells. Viability, protein expression, NF-κB binding activity, invasion, anoikis, and spheroid formation were examined in cells expressing high or low levels of IKKε, in conjunction with p52 RNA interference or MEK inhibition.
Results
This study found that non-canonical NF-κB p52 levels are inversely proportional to ΙΚΚε, and growth of TNBC cells in anchorage supportive, high-attachment conditions requires IKKε and activated MEK. Growth of these cells in anchorage resistant conditions requires IKKε and activated MEK or p52. In this model, IKKε and MEK cooperate to support overall viability whereas the p52 transcription factor is only required for viability in low attachment conditions, underscoring the contrasting roles of these proteins.
Conclusions
This study illustrates the diverse functions of IKKε in TNBC and highlights the adaptability of NF-κB signaling in maintaining cancer cell survival under different growth conditions. A better understanding of the diversity of NF-κB signaling may ultimately improve the development of novel therapeutic regimens for TNBC.
https://ift.tt/2s7JWkP
Identification of genes inducing resistance to ionizing radiation in human rectal cancer cell lines: re-sensitization of radio-resistant rectal cancer cells through down regulating NDRG1
Abstract
Background
Resistance to preoperative radiotherapy is a major clinical problem in the treatment for locally advanced rectal cancer. The role of NDRG1 in resistance to ionizing radiation in rectal cancer has not been fully elucidated. This study aimed to investigate the effect of the reduced intracellular NDRG1 expression on radio-sensitivity of human rectal cancer cells for exploring novel approaches for treatment of rectal cancer.
Methods
Three radio-resistant human rectal cancer cell lines (SNU-61R80Gy, SNU-283R80Gy, and SNU-503R80Gy) were established from human rectal cancer cell lines (SNU-61, SNU-283, and SNU-503) using total 80 Gy of fractionated irradiation. Microarray analysis was performed to identify differently expressed genes in newly established radio-resistant human rectal cancer cells compared to parental rectal cancer cells.
Results
A microarray analysis indicated the RNA expression of five genes (NDRG1, ERRFI1, H19, MPZL3, and UCA1) was highly increased in radio-resistant rectal cancer cell lines. Short hairpin RNA-mediated silencing of NDRG1 sensitized rectal cancer cell lines to clinically relevant doses of radiation by causing more DNA double strand breakages to rectal cancer cells when exposed to radiation.
Conclusions
Targeting NDRG1 represents a promising strategy to increase response to radiotherapy in human rectal cancer.
https://ift.tt/2IJMxaU
In vivo evaluation of two tissue transglutaminase PET tracers in an orthotopic tumour xenograft model
Abstract
Background
The protein cross-linking enzyme tissue transglutaminase (TG2; EC 2.3.2.13) is associated with the pathogenesis of various diseases, including cancer. Recently, the synthesis and initial evaluation of two high-potential radiolabelled irreversible TG2 inhibitors were reported by us. In the present study, these two compounds were evaluated further in a breast cancer (MDA-MB-231) tumour xenograft model for imaging active tissue transglutaminase in vivo.
Results
The metabolic stability of [11C]1 and [18F]2 in SCID mice was comparable to the previously reported stability in Wistar rats. Quantitative real-time polymerase chain reaction analysis on MDA-MB-231 cells and isolated tumours showed a high level of TG2 expression with very low expression of other transglutaminases. PET imaging showed low tumour uptake of [11C]1 (approx. 0.5 percentage of the injected dose per gram (%ID/g) at 40–60 min p.i.) and with relatively fast washout. Tumour uptake for [18F]2 was steadily increasing over time (approx. 1.7 %ID/g at 40–60 min p.i.). Pretreatment of the animals with the TG2 inhibitor ERW1041E resulted in lower tumour activity concentrations, and this inhibitory effect was enhanced using unlabelled 2.
Conclusions
Whereas the TG2 targeting potential of [11C]1 in this model seems inadequate, targeting of TG2 using [18F]2 was achieved. As such, [18F]2 could be used in future studies to clarify the role of active tissue transglutaminase in disease.
https://ift.tt/2Lwo3n9
Cancers, Vol. 10, Pages 161: KLF10 as a Tumor Suppressor Gene and Its TGF-β Signaling
Cancers, Vol. 10, Pages 161: KLF10 as a Tumor Suppressor Gene and Its TGF-β Signaling
Cancers doi: 10.3390/cancers10060161
Authors: Azra Memon Woon Kyu Lee
Krüppel-like factor 10 (KLF10), originally named TGF-β (Transforming growth factor beta) inducible early gene 1 (TIEG1), is a DNA-binding transcriptional regulator containing a triple C2H2 zinc finger domain. By binding to Sp1 (specificity protein 1) sites on the DNA and interactions with other regulatory transcription factors, KLF10 encourages and suppresses the expression of multiple genes in many cell types. Many studies have investigated its signaling cascade, but other than the TGF-β/Smad signaling pathway, these are still not clear. KLF10 plays a role in proliferation, differentiation as well as apoptosis, just like other members of the SP (specificity proteins)/KLF (Krüppel-like Factors). Recently, several studies reported that KLF10 KO (Knock out) is associated with defects in cell and organs such as osteopenia, abnormal tendon or cardiac hypertrophy. Since KLF10 was first discovered, several studies have defined its role in cancer as a tumor suppressor. KLF10 demonstrate anti-proliferative effects and induce apoptosis in various carcinoma cells including pancreatic cancer, leukemia, and osteoporosis. Collectively, these data indicate that KLF10 plays a significant role in various biological processes and diseases, but its role in cancer is still unclear. Therefore, this review was conducted to describe and discuss the role and function of KLF10 in diseases, including cancer, with a special emphasis on its signaling with TGF-β.
https://ift.tt/2LuFDYB
In vitro-induced erythromycin resistance facilitates cross-resistance to the novel fluoroketolide, solithromycin, in Staphylococcus aureus
https://ift.tt/2x7k0dQ
Automated Pulmonary Embolism Risk Classification and Guideline Adherence for Computed Tomography Pulmonary Angiography Ordering
Academic Emergency Medicine, EarlyView.
https://ift.tt/2s8Fxgo
Slow Infusion of Low‐dose Ketamine Reduces Bothersome Side Effects Compared to Intravenous Push: A Double‐blind, Double‐dummy, Randomized Controlled Trial
Academic Emergency Medicine, EarlyView.
https://ift.tt/2kpEWDB
The Banner of Hope and Solidarity After Mass Murder
Academic Emergency Medicine, EarlyView.
https://ift.tt/2s8FsJC
Regulatory NK1.1 − CD4 + NKG2D + subset induced by NKG2DL + cells promotes tumor evasion in mice
Abstract
Regulatory T cells play critical roles in self-tolerance and tumor evasion. CD4+NKG2D+ cells with regulatory activity are present in patients with NKG2DL+ tumors and juvenile systemic lupus erythematosus. We previously showed that TGF-β-producing CD4+NKG2D+ T cells are present in pCD86-Rae-1ε transgenic mice. Here, we performed both ex vivo and in vivo studies on pCD86-Rae-1ε transgenic mice and an MC38 tumor-bearing mouse model and show that NK1.1−CD4+NKG2D+ T cells have regulatory activity in pCD86-Rae-1ε transgenic mice. Furthermore, this T-cell subset was induced in mice transplanted with NKG2DL+ tumor cells and produced TGF-β and FasL, and secreted low amounts of IFN-γ. This T-cell subset downregulated the function of effector T cells and dendritic cells, which were abolished by anti-TGF-β antibody. In vivo, adoptive transfer of NK1.1−CD4+NKG2D+ T cells promoted TGF-β-dependent tumor growth in mice. We further found that ex vivo induction of NK1.1−CD4+NKG2D+ T cells was dependent on both anti-CD3 and NKG2DL stimulation. Furthermore, regulatory NK1.1−CD4+NKG2D+ T cells did not express Foxp3 or CD25 and expressed intermediate levels of T-bet. Western-blotting showed that STAT3 signaling was activated in NK1.1−CD4+NKG2D+ T cells of MC38 tumor-bearing and pCD86-Rae-1ε transgenic mice. In conclusion, we describe a regulatory NK1.1−CD4+NKG2D+ T-cell population, different from other regulatory T cells and abnormally elevated in pCD86-Rae-1ε transgenic and MC38 tumor-bearing mice.
https://ift.tt/2Lo5mlH
Maternal nutrient restriction in baboon programs later-life cellular growth and respiration of cultured skin fibroblasts: a potential model for the study of aging-programming interactions
Abstract
Compelling data exist for programming of chronic later-life diseases and longevity by perinatal developmental programming challenges. Understanding mechanisms by which life course health trajectory and longevity are set is fundamental to understanding aging. Appropriate approaches are needed to determine programming effects on cellular function. We have developed a baboon model in which control mothers eat ad libitum while a second group eat 70% of the global diet fed controls, leading to male and female offspring intrauterine growth restriction (IUGR). We have shown that IUGR suffer from acceleration of several age-related physiological declines. Here, we report on a skin-derived fibroblast model with potential relevance for mechanistic studies on how IUGR impacts aging. Fibroblasts were cultured from the skin biopsies taken from adult baboons from control and IUGR cohorts. IUGR-derived fibroblasts grew in culture less well than controls and those derived from male, but not female, IUGR baboons had a significant reduction in maximum respiration rate compared to control-derived fibroblasts. We also show that relative levels of several mitochondrial protein subunits, including NDUFB8 and cytochrome c oxidase subunit IV, were reduced in IUGR-derived fibroblasts even after serial passaging in culture. The lower levels of electron transport system components provide potential mechanisms for accelerated life course aging in the setting of programmed IUGR. This observation fits with the greater sensitivity of males compared with females to many, but not all, outcomes in response to programming challenges. These approaches will be powerful in the determination of programming-aging interactions.
https://ift.tt/2J5ywaM
Regulatory NK1.1 − CD4 + NKG2D + subset induced by NKG2DL + cells promotes tumor evasion in mice
Abstract
Regulatory T cells play critical roles in self-tolerance and tumor evasion. CD4+NKG2D+ cells with regulatory activity are present in patients with NKG2DL+ tumors and juvenile systemic lupus erythematosus. We previously showed that TGF-β-producing CD4+NKG2D+ T cells are present in pCD86-Rae-1ε transgenic mice. Here, we performed both ex vivo and in vivo studies on pCD86-Rae-1ε transgenic mice and an MC38 tumor-bearing mouse model and show that NK1.1−CD4+NKG2D+ T cells have regulatory activity in pCD86-Rae-1ε transgenic mice. Furthermore, this T-cell subset was induced in mice transplanted with NKG2DL+ tumor cells and produced TGF-β and FasL, and secreted low amounts of IFN-γ. This T-cell subset downregulated the function of effector T cells and dendritic cells, which were abolished by anti-TGF-β antibody. In vivo, adoptive transfer of NK1.1−CD4+NKG2D+ T cells promoted TGF-β-dependent tumor growth in mice. We further found that ex vivo induction of NK1.1−CD4+NKG2D+ T cells was dependent on both anti-CD3 and NKG2DL stimulation. Furthermore, regulatory NK1.1−CD4+NKG2D+ T cells did not express Foxp3 or CD25 and expressed intermediate levels of T-bet. Western-blotting showed that STAT3 signaling was activated in NK1.1−CD4+NKG2D+ T cells of MC38 tumor-bearing and pCD86-Rae-1ε transgenic mice. In conclusion, we describe a regulatory NK1.1−CD4+NKG2D+ T-cell population, different from other regulatory T cells and abnormally elevated in pCD86-Rae-1ε transgenic and MC38 tumor-bearing mice.
https://ift.tt/2Lo5mlH
Preparation times and costs for various solutions used for continuous renal replacement therapy [Practice Research Report]
Purpose
Results of a study to determine time and cost requirements for final preparation of continuous renal replacement therapy (CRRT) products are reported.
MethodsA 3-phase observational study was conducted at a tertiary care university hospital to evaluate costs associated with manual addition of phosphate and/or potassium to 3 commercial 5-L CRRT products. In the first phase of the study, pharmacy workflow processes for solution preparation were established; in the second phase, pharmacist and pharmacy technician time spent in the CRRT workflow and all materials used were observed and recorded. In the third phase, time and personnel requirements were analyzed in economic terms to estimate final preparation costs.
ResultsThrough direct observation over 35 days, the CRRT workflow was observed and work times recorded for 511 bag preparations. The main cost contributors were the base CRRT solution and electrolyte additive prices. Technician compounding time differed substantially by solution brand and the need for electrolyte addition. Pharmacist verification time did not differ meaningfully by product.
ConclusionPreparation and verification of premade CRRT solutions that contained physiological electrolyte concentrations required less technician and pharmacist time than solutions that needed addition of electrolytes in the pharmacy. Personnel costs, which were a small part of the total cost of dispensed CRRT bags, were higher for technicians than pharmacists. The baseline costs of the solutions and the electrolyte additives, if needed, were the main contributors to total cost.
https://ift.tt/2J8hkSa
Roles of the emergency medicine pharmacist: A systematic review [Practice Research Report]
Purpose
Results of a systematic literature review to identify roles for emergency medicine (EM) pharmacists beyond traditionally reported activities and to quantify the benefits of these roles in terms of patient outcomes are reported.
SummaryEmergency department (ED)–based clinical pharmacy is a rapidly growing practice area that has gained support in a number of countries globally, particularly over the last 5–10 years. A systematic literature search covering the period 1995–2016 was conducted to characterize emerging EM pharmacist roles and the impact on patient outcomes. Six databases were searched for research publications on pharmacist participation in patient care in a general ED or trauma center that documented interventions by ED-based pharmacists; 15 results satisfied the inclusion criteria. Six reported studies evaluated EM pharmacist involvement in the care of critically ill patients, 5 studies evaluated antimicrobial stewardship (AMS) activities via pharmacist review of positive cultures, 2 studies assessed pharmacist involvement in generating orders for nurse-administered home medications and 2 reviewed publications focused on EM pharmacist involvement in management of healthcare-associated pneumonia and dosing of phenytoin. A diverse range of positive patient outcomes was identified. The included studies were assessed to be of low quality.
ConclusionA systematic review of the literature revealed 3 key emerging areas of practice for the EM pharmacist that are associated with positive patient outcomes. These included involvement in management of critically ill patients, AMS roles, and ordering of home medications in the ED.
https://ift.tt/2LsjM48
Proprotein convertase subtilisin/kexin type 9 inhibitors for reduction of cardiovascular events [Clinical Review]
Purpose
The efficacy, safety, and place in therapy of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for lipid lowering are reviewed.
SummaryPCSK9 inhibitors are injectable monoclonal antibodies that increase the availability of low-density lipoprotein (LDL) receptors, resulting in a reduction in serum LDL cholesterol (LDL-C). The currently available PCSK9 inhibitors alirocumab and evolocumab were shown to reduce LDL-C concentrations by approximately 55–60% relative to placebo use when used as monotherapy or added to other lipid-lowering therapies. A large randomized controlled trial of evolocumab demonstrated a reduction in cardiovascular events that translated to a 16% relative risk reduction per 1-mmol/L (39-mg/dL) reduction in LDL-C over 2 years, nearly identical to risk reductions reported with use of statins for LDL-C lowering. Another large outcome trial with alirocumab is ongoing. PCSK9 inhibitors are well tolerated, and minor injection-site reaction is the only known adverse effect. Routine use of these agents in all patients with cardiovascular disease is not cost-effective at the current annual cost of therapy of approximately $14,000 in the United States and $7,000 in other Western countries. Careful patient selection may increase the benefit-to-cost ratio of these agents.
ConclusionThe PCSK9 inhibitors alirocumab and evolocumab, as adjuncts to oral lipid-lowering agents or as monotherapy, lower serum LDL-C concentrations and reduce the risk of cardiovascular events. These agents are safe and well tolerated, but high cost and lack of cost-effectiveness limit their routine use.
https://ift.tt/2GQ3YER
Pharmacotherapy considerations for long-term management of patients with left ventricular assist devices [Clinical Review]
Purpose
Current guidelines and research pertaining to pharmacotherapy considerations for management of patients with left ventricular assist devices (LVADs) are reviewed.
SummaryLVADs are being used more frequently to sustain patients with end-stage heart failure who are on a waitlist or ineligible for heart transplantation. The devices significantly impact patient physiology leading to unique medical complications and pharmacotherapy considerations. Pharmacists can play a vital role in understanding and relaying relevant medication concerns to the interdisciplinary healthcare team. Although optimal treatment regimens for some complications are still unclear, evolving research provides key information to incorporate into decisions. The introduction of an LVAD requires antithrombotic therapy in the absence of contraindications to prevent thrombosis. Warfarin with a device-dependent International Normalized Ratio (INR) goal is preferred. The baseline INR goal is usually 2–3 but can be adjusted for recurrent thrombosis or refractory bleeding. When infection is suspected, cultures should be obtained, covering likely pathogens with consideration of resistance in long-standing infections. Chronic antimicrobial suppression may be warranted. Elimination rate constant and volume of distribution may be altered. LVAD implantation may improve glycemic control. Doppler probe is preferred to monitor blood pressure, with a goal mean arterial pressure of ≤80 mm Hg.
ConclusionMany pharmacotherapy considerations are necessary for the long-term management of patients with an LVAD. Awareness of LVAD structure, pathophysiologic alterations after LVAD implantation, and pharmacologic considerations will help pharmacists provide better recommendations.
https://ift.tt/2LskKgU
Catastrophic circulatory collapse after inadvertent subcutaneous injection of treprostinil [Case Report]
Purpose
A case of life-threatening cardiovascular collapse after inadvertent subcutaneous injection of undiluted treprostinil is reported.
SummaryA 29-year-old, 76-kg woman with group 1 pulmonary arterial hypertension managed with subcutaneous treprostinil infusion arrived at the emergency department (ED) with headache, nausea, vomiting, and a syncopal episode. Her vital signs were stable on presentation. Admission orders were placed, and the appropriate 3-mL syringe containing 7.5 mg of treprostinil intended for use with the patient's home microinfusion pump was sent from inpatient pharmacy to the ED. The order in the electronic medical record stated to administer treprostinil as a subcutaneous injection rather than an infusion. The patient's nurse transferred the 7.5 mg (3 mL) of undiluted treprostinil to a standard syringe and administered it as a single subcutaneous injection. Within minutes the patient experienced cardiovascular collapse, with a blood pressure nadir of 50/20 mm Hg. Aggressive resuscitation measures were immediately implemented. Initial management included fluids, bolus-dose vasopressors, multiple high-dose vasopressor infusions, ondansetron, acetaminophen, and loperamide. Hemodynamic stability was achieved, and vasopressors were discontinued 16 hours after the overdose event. Subcutaneous treprostinil was restarted at a reduced dose 12 hours after the overdose event and was adjusted to the patient's home dose 24 hours after the initial event. She was discharged in stable condition 30 hours after the overdose event.
ConclusionA patient who received an inadvertent overdose of subcutaneous treprostinil experienced cardiovascular collapse requiring aggressive resuscitation measures. Successful management of the patient was largely supportive, including fluids, bolus-dose vasopressors, multiple high-dose vasopressor infusions, ondansetron, acetaminophen, and loperamide.
https://ift.tt/2KSTmY5
Incorporating medication indications into the prescribing process [Special Feature]
Purpose
The incorporation of medication indications into the prescribing process to improve patient safety is discussed.
SummaryCurrently, most prescriptions lack a key piece of information needed for safe medication use: the patient-specific drug indication. Integrating indications could pave the way for safer prescribing in multiple ways, including avoiding look-alike/sound-alike errors, facilitating selection of drugs of choice, aiding in communication among the healthcare team, bolstering patient understanding and adherence, and organizing medication lists to facilitate medication reconciliation. Although strongly supported by pharmacists, multiple prior attempts to encourage prescribers to include the indication on prescriptions have not been successful. We convened 6 expert panels to consult high-level stakeholders on system design considerations and requirements necessary for building and implementing an indications-based computerized prescriber order-entry (CPOE) system. We summarize our findings from the 6 expert stakeholder panels, including rationale, literature findings, potential benefits, and challenges of incorporating indications into the prescribing process. Based on this stakeholder input, design requirements for a new CPOE interface and workflow have been identified.
ConclusionThe emergence of universal electronic prescribing and content knowledge vendors has laid the groundwork for incorporating indications into the CPOE prescribing process. As medication prescribing moves in the direction of inclusion of the indication, it is imperative to design CPOE systems to efficiently and effectively incorporate indications into prescriber workflows and optimize ways this can best be accomplished.
https://ift.tt/2Lt2IuI
Primary adrenal diffuse large B cell lymphoma: a clinicopathological and molecular study from China
Abstract
Primary adrenal lymphoma is a rare entity that, in most cases, is derived from B cells. The most commonly seen primary adrenal lymphoma is diffuse large B cell lymphoma (DLBCL). To better understand the clinicopathological and molecular features of these tumors, we studied 14 Chinese patients with DLBCL who initially presented with an adrenal tumor. The clinicopathological features of the 14 primary adrenal DLBCL cases were retrospectively reviewed using immunohistochemistry, immunoglobulin gene rearrangement analysis, evaluation of Epstein-Barr virus status, and fluorescence in situ hybridization. Patient age ranged from 43 to 69 years, with a mean age of 58 years. The patients most commonly presented with abdominal pain and adrenal mass. Ten patients exhibited bilateral adrenal masses, and four had unilateral adrenal masses (three left, one right). Thirteen of 14 DLBCLs were DLBCL not otherwise specified, and one was an intravascular large B cell lymphoma. According to the algorithm of Hans et al. (Blood 103:275–282, 2004), 13 and 1 cases were classified as the non-germinal center B-cell-like subtype and the germinal center B-cell-like subtype, respectively. The Ki-67 index ranged from 35 to 80%. Epstein-Barr virus-encoded RNA was detected by in situ hybridization in 6 of the 12 available cases. Two patients showed BCL-6 rearrangements. The follow-up period ranged from 1 to 87 months. During the follow-up period, four patients died of the disease, five were alive with the disease, four were alive without disease, and one was lost during the follow-up period. In summary, most primary adrenal lymphomas are non-germinal-center B-cell-like subtype DLBCLs, which have high proliferative activity and a poor prognosis.
https://ift.tt/2xaBOoy
Cancers, Vol. 10, Pages 160: A Phase II Study of Pelareorep (REOLYSIN®) in Combination with Gemcitabine for Patients with Advanced Pancreatic Adenocarcinoma
Cancers, Vol. 10, Pages 160: A Phase II Study of Pelareorep (REOLYSIN®) in Combination with Gemcitabine for Patients with Advanced Pancreatic Adenocarcinoma
Cancers doi: 10.3390/cancers10060160
Authors: Devalingam Mahalingam Sanjay Goel Santiago Aparo Sukeshi Patel Arora Nicole Noronha Hue Tran Romit Chakrabarty Giovanni Selvaggi Andres Gutierrez Matthew Coffey Steffan T. Nawrocki Gerard Nuovo Monica M. Mita
Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis, with 1 and 5-year survival rates of ~18% and 7% respectively. FOLFIRINOX or gemcitabine in combination with nab-paclitaxel are standard treatment options for metastatic disease. However, both regimens are more toxic than gemcitabine alone. Pelareorep (REOLYSIN®), a proprietary isolate of reovirus Type 3 Dearing, has shown antitumor activity in clinical and preclinical models. In addition to direct cytotoxic effects, pelareorep can trigger antitumor immune responses. Due to the high frequency of RAS mutations in PDAC, we hypothesized that pelareorep would promote selective reovirus replication in pancreatic tumors and enhance the anticancer activity of gemcitabine. Chemotherapy-naïve patients with advanced PDAC were eligible for the study. The primary objective was Clinical Benefit Rate (complete response (CR) + partial response (PR) + stable disease (SD) ≥ 12 weeks) and secondary objectives include overall survival (OS), toxicity, and pharmacodynamics (PD) analysis. The study enrolled 34 patients; results included one partial response, 23 stable disease, and 5 progressive disease. The median OS was 10.2 months, with a 1- and 2-year survival rate of 45% and 24%, respectively. The treatment was well tolerated with manageable nonhematological toxicities. PD analysis revealed reovirus replication within pancreatic tumor and associated apoptosis. Upregulation of immune checkpoint marker PD-L1 suggests future consideration of combining oncolytic virus therapy with anti-PD-L1 inhibitors. We conclude that pelareorep complements single agent gemcitabine in PDAC.
https://ift.tt/2xbPU8Z
Cancers, Vol. 10, Pages 159: Deregulation of Negative Controls on TGF-β1 Signaling in Tumor Progression
Cancers, Vol. 10, Pages 159: Deregulation of Negative Controls on TGF-β1 Signaling in Tumor Progression
Cancers doi: 10.3390/cancers10060159
Authors: Jiaqi Tang Cody C. Gifford Rohan Samarakoon Paul J. Higgins
The multi-functional cytokine transforming growth factor-β1 (TGF-β1) has growth inhibitory and anti-inflammatory roles during homeostasis and the early stages of cancer. Aberrant TGF-β activation in the late-stages of tumorigenesis, however, promotes development of aggressive growth characteristics and metastatic spread. Given the critical importance of this growth factor in fibrotic and neoplastic disorders, the TGF-β1 network is subject to extensive, multi-level negative controls that impact receptor function, mothers against decapentaplegic homolog 2/3 (SMAD2/3) activation, intracellular signal bifurcation into canonical and non-canonical pathways and target gene promotor engagement. Such negative regulators include phosphatase and tensin homologue (PTEN), protein phosphatase magnesium 1A (PPM1A), Klotho, bone morphogenic protein 7 (BMP7), SMAD7, Sloan-Kettering Institute proto-oncogene/ Ski related novel gene (Ski/SnoN), and bone morphogenetic protein and activin membrane-bound Inhibitor (BAMBI). The progression of certain cancers is accompanied by loss of expression, overexpression, mislocalization, mutation or deletion of several endogenous repressors of the TGF-β1 cascade, further modulating signal duration/intensity and phenotypic reprogramming. This review addresses how their aberrant regulation contributes to cellular plasticity, tumor progression/metastasis and reversal of cell cycle arrest and discusses the unexplored therapeutic value of restoring the expression and/or function of these factors as a novel approach to cancer treatment.
https://ift.tt/2J48IMl
Hunting the G-unit in Huntington’s
https://ift.tt/2IPabCR
Editorial
https://ift.tt/2LvHpJg
Synaptic assays: using biophysical models to infer neuronal dysfunction from non-invasive EEG
https://ift.tt/2IKjbJq
Can we use regional grey matter atrophy sequence to stage neurodegeneration in multiple sclerosis?
https://ift.tt/2Lsak0E
Chasing the start of sporadic Alzheimer’s disease running in families
https://ift.tt/2xavz46
JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis
https://ift.tt/2Lw8hsi
Progression of regional grey matter atrophy in multiple sclerosis
https://ift.tt/2IJzKFg
Ion channels in EEG: isolating channel dysfunction in NMDA receptor antibody encephalitis
https://ift.tt/2Lv92lC
Retraining speech production and fluency in non-fluent/agrammatic primary progressive aphasia
https://ift.tt/2INwAjU
Mutations in COA7 cause spinocerebellar ataxia with axonal neuropathy
https://ift.tt/2Lr3jgy
Cerebello-cortical network fingerprints differ between essential, Parkinson’s and mimicked tremors
https://ift.tt/2IK6um3
Effects of the SGLT-2 Inhibitor Empagliflozin on Renal Tissue Oxygenation in Non-Diabetic Subjects: A Randomized, Double-Blind, Placebo-Controlled Study Protocol
Abstract
Introduction
Empagliflozin is an SGLT-2 inhibitor (SGLT-2i) which belongs to a new class of hypoglycemic drugs with the unique property of decreasing blood glucose independently from insulin, through an increase in glycosuria. In addition to decreasing cardiovascular morbidity and mortality, empagliflozin has nephroprotective properties in high cardiovascular risk patients with type 2 diabetes. Decreased hyperfiltration and shifting towards more favorable renal fuel energetics with improved renal oxygenation may explain some of these properties. With this study, we propose to explore the effects of empagliflozin on renal tissue oxygenation using blood oxygenation level-dependent magnetic resonance imaging (BOLD-MRI).
Methods
This is a double-blind, randomized, placebo-controlled study examining the acute and chronic renal effects of empagliflozin 10 mg. The primary outcome is the effects of empagliflozin on renal tissue oxygenation as measured by BOLD-MRI. The secondary outcomes include the effects of empagliflozin on tubular function, 24 h blood pressure control, and the influence of body mass index (BMI) on the renal response to empagliflozin. Fifteen normal weight, 15 overweight, and 15 obese non-diabetic subjects (men and women) will be recruited. Each participant will undergo 24 h urine collections and blood pressure measurements on day − 1, followed by an investigation day at the study center with blood and urine sampling and renal BOLD-MRI measurements before and 180 min after the administration of 10 mg empagliflozin or placebo. This sequence of measurements will be repeated after 1 month of a daily empagliflozin or placebo intake. To investigate renal oxygenation, the renal cortical and medullary R2*, as a marker of oxygenation, will be assessed by BOLD-MRI under standardized hydration conditions: the higher R2*, the lower oxygenation.
Conclusion
SGLT-2 inhibitors have a profound effect on renal physiology. This is an important study that will explore for the first time whether inhibiting SGLT-2 with empagliflozin in healthy volunteers affects renal tissue oxygenation as determined by BOLD-MRI.
Funding
Boehringer Ingelheim Pharma GmbH & Co.
Trial registration
ClinicalTrials.gov identifier, NCT03093103.
https://ift.tt/2scMT2z
Conjunctival Melanoma - Epidemiological Trends and Features
Abstract
Conjunctival melanoma is a rare but sight and life threatening malignancy. It accounts for 2%–5% of all ocular tumours and 5%–7% of all ocular melanomas with an incidence of 0.2–0.8 per million in the Caucasian population with rare cases reported in the non-Caucasians. In recent decades the incidence of uveal melanoma has been relatively stable whilst conjunctival and cutaneous melanoma have shown increasing incidence which may be connected to the result of environmental exposure to ultraviolet light. The dissimilarity in incidence between light and dark pigmented individuals observed in conjunctival melanomas compared to uveal and cutaneous melanomas may be related to differences in their histological structures and genetic profile. Recent molecular biological studies support the fact that each type of melanoma undergoes its own molecular changes and has characteristic biological behaviour. Further studies are required for each type of melanoma in order to ascertain their individual etiology and pathogenesis and based on this knowledge develop relevant preventative and treatment procedures.
https://ift.tt/2s5FLFV
Pharmacodynamic study using FLT PET/CT in advanced solid malignancies treated with a sequential combination of X-82 and docetaxel
Abstract
Background
A sequential approach, synchronizing cell-cycle specific chemotherapy during VEGFR-TKI treatment breaks, may improve the therapeutic index of this combination therapy. In this study we investigate the safety/tolerability and pharmacodynamic effects of docetaxel used in sequential combination with the novel VEGFR-TKI X-82.
Methods
Patients with advanced solid malignancies underwent 21-day treatment cycles with X-82 administered daily on days 1–14, a treatment break on days 15–20, and docetaxel administered on day 21. Randomization was 1:1 to either a low-dose X-82 (200 mg) or high-dose X-82 (400 mg) arm. Patients were scheduled to undergo four 3′-deoxy-3′-18F-fluorothymidine (FLT) PET/CT scans to assess changes in tumor cell proliferation. PET standardized uptake values (SUV) were summarized for tumors and changes were assessed using mixed effects models.
Results
14 patients were enrolled and treated with median 3.5 cycles (range 0–12). Three patients in the high-dose cohort (50%) and three patients in the low-dose cohort (38%) experienced at least one grade 3 adverse event during the study (infections, cytopenias, electrolyte abnormalities, and vascular complications). Four patients with 13 metastatic tumors underwent FLT PET/CT scanning. During the cycle 1 X-82 exposure period, tumor SUVmax decreased by − 11% (p = 0.04). After administration of docetaxel and the cycle 2 X-82 exposure period, tumor SUVmax decreased − 44% (p = 0.03).
Conclusions
The sequential combination of X-82 and docetaxel was safe and led to diminished FLT uptake. Further, decrease in FLT uptake during cycle 2 (X-82 plus docetaxel) was greater than in cycle 1 (X-82 alone), suggesting sequential chemotherapy enhances the pharmacodynamic effect of therapy.
https://ift.tt/2LtnZVa
IL13Rα2 expression identifies tissue‐resident IL‐22‐producing PLZF+ innate T cells in the human liver
European Journal of Immunology, EarlyView.
https://ift.tt/2s9w7S1
Assessing the Recall Rate for Screening Mammography: Comparing the Medicare Hospital Compare Dataset With the National Mammography Database
American Journal of Roentgenology, Ahead of Print.
https://ift.tt/2kpOKxH
Interpretation Time Using a Concurrent-Read Computer-Aided Detection System for Automated Breast Ultrasound in Breast Cancer Screening of Women With Dense Breast Tissue
American Journal of Roentgenology, Ahead of Print.
https://ift.tt/2x95J08
Screening Mammography Findings From One Standard Projection Only in the Era of Full-Field Digital Mammography and Digital Breast Tomosynthesis
American Journal of Roentgenology, Ahead of Print.
https://ift.tt/2kmWmAV
Mesenchymal Lesions of the Breast: What Radiologists Need to Know
American Journal of Roentgenology, Ahead of Print.
https://ift.tt/2s6NBOS
Integrated Interventional Radiology Residency Program Websites: A Development in Progress
American Journal of Roentgenology, Ahead of Print.
https://ift.tt/2kpYTdG
Overutilization of Health Care Resources for Breast Pain
American Journal of Roentgenology, Ahead of Print.
https://ift.tt/2s6Nu5U
Portal Vein Thrombosis: Imaging the Spectrum of Disease With an Emphasis on MRI Features
American Journal of Roentgenology, Ahead of Print.
https://ift.tt/2xhUkeu
High-Resolution CT Findings of Obstructive and Restrictive Phenotypes of Chronic Lung Allograft Dysfunction: More Than Just Bronchiolitis Obliterans Syndrome
American Journal of Roentgenology, Ahead of Print.
https://ift.tt/2J1Q5IX
Postoperative MRI of Massive Rotator Cuff Tears
American Journal of Roentgenology, Ahead of Print.
https://ift.tt/2xeBNA0
JOURNAL CLUB: Extracolonic Findings at CT Colonography: Systematic Review and Meta-Analysis
American Journal of Roentgenology, Ahead of Print.
https://ift.tt/2J1PYNx
Lesions of Ligamentum Teres: Diagnostic Performance of MRI and MR Arthrography—A Systematic Review and Meta-Analysis
American Journal of Roentgenology, Ahead of Print.
https://ift.tt/2xbTgJe
-
Αλέξανδρος Γ. Σφακιανάκης Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,0030693260717...
-
heory of COVID-19 pathogenesis Publication date: November 2020Source: Medical Hypotheses, Volume 144Author(s): Yuichiro J. Suzuki ScienceD...
-
https://ift.tt/2MQ8Ai8